Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
25.29
+2.79 (12.40%)
At close: Mar 6, 2026, 4:00 PM EST
25.25
-0.04 (-0.16%)
After-hours: Mar 6, 2026, 4:19 PM EST

Sutro Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2016
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2016
Market Capitalization
414152261464689988
Upgrade
Market Cap Growth
168.78%-41.98%-43.69%-32.55%-30.31%288.95%
Upgrade
Enterprise Value
243-212-55193453731
Upgrade
Last Close Price
22.5018.4042.9080.80148.80217.10
Upgrade
PS Ratio
3.722.441.706.8511.1323.12
Upgrade
PB Ratio
-3.401.752.142.732.98
Upgrade
P/TBV Ratio
-3.401.752.142.732.98
Upgrade
P/OCF Ratio
---130.85--
Upgrade
EV/Sales Ratio
2.30--2.857.3217.11
Upgrade
Debt / Equity Ratio
-0.200.520.230.230.230.07
Upgrade
Net Debt / Equity Ratio
1.72-6.59-2.28-1.31-0.83-1.03
Upgrade
Net Debt / EBITDA Ratio
1.161.274.152.302.245.15
Upgrade
Net Debt / FCF Ratio
0.671.512.9565.892.164.59
Upgrade
Asset Turnover
0.320.140.350.180.170.16
Upgrade
Quick Ratio
2.392.474.395.135.0412.63
Upgrade
Current Ratio
2.532.604.505.315.2412.78
Upgrade
Return on Equity (ROE)
-1810.01%-234.19%-58.25%-50.77%-36.10%-14.95%
Upgrade
Return on Assets (ROA)
-25.80%-34.74%-12.72%-21.54%-16.74%-16.13%
Upgrade
Return on Capital Employed (ROCE)
-99.10%-93.40%-23.70%-37.90%-32.90%-19.50%
Upgrade
Earnings Yield
-55.11%-149.92%-40.84%-25.67%-15.33%-3.25%
Upgrade
FCF Yield
-57.24%-128.28%-44.34%-0.93%-14.09%-7.58%
Upgrade
Buyback Yield / Dilution
-17.26%-27.70%-18.57%-10.02%-41.59%-41.88%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.